Position in CADL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,073,630
-$449,312 QoQ
Shares Held
1,035,435
+5.9% QoQ
Ownership
1.41%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. CADL ranks #213 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in CADL
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,073,630 | 1,035,435 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,522,942 | 977,512 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $4,733,803 | 928,197 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,574,087 | 903,970 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $3,884,153 | 687,461 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,953,079 | 455,424 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,111,548 | 448,997 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,466,892 | 397,886 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $230,215 | 145,706 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $204,701 | 139,253 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $128,112 | 139,253 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $165,315 | 131,203 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $177,124 | 131,203 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $234,853 | 131,203 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $404,576 | 128,846 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $243,703 | 75,217 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $382,854 | 75,217 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $455,788 | 58,285 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $221,081 | 20,395 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||